Platelet Expression and Reactivity in Kidney Disease
Author Information
Author(s): Serrano Feliciano A, El-Shahawy Mohamed, Solomon Richard J, Sobel Burton E, Schneider David J
Primary Institution: University of Vermont
Hypothesis
Does increased expression of FcGammaRIIA impact platelet reactivity in patients with end stage renal disease?
Conclusion
High platelet expression of FcGammaRIIA is linked to increased platelet reactivity, which may raise the risk of thrombosis in patients with end stage renal disease.
Supporting Evidence
- Patients with high FcGammaRIIA expression had 3-fold greater platelet reactivity to convulxin.
- Increased platelet reactivity was also observed in response to thrombin, ADP, and PAF.
- The study suggests a link between FcGammaRIIA expression and cardiovascular risk in ESRD patients.
Takeaway
Patients with kidney disease who have more of a certain protein on their platelets are more likely to have their platelets activate, which can lead to blood clots.
Methodology
Blood samples were taken from patients before hemodialysis to measure platelet expression and reactivity using flow cytometry.
Potential Biases
Potential confounding variables were not fully controlled due to the limited sample size.
Limitations
The sample size is limited, which may affect the ability to generalize the findings.
Participant Demographics
Patients were adults over 18 years old undergoing hemodialysis for ESRD.
Statistical Information
P-Value
p < 0.01 for convulxin, p < 0.05 for thrombin, ADP, and PAF
Statistical Significance
p < 0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website